Lane Manning said he got word of a Regeneron trial at UW-Health, the study which examines an experimental drug, that is trying to stop COVID-19 in its tracks. He signed up right away.
Office of Strategic Communication
Lane Manning said he got word of a Regeneron trial at UW-Health, the study which examines an experimental drug, that is trying to stop COVID-19 in its tracks. He signed up right away.